Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

Search results

• Finished

  MASTER MIND - MRC ABPI Stratification and Extreme Response Mechanism in Type 2 Diabetes (Joint with University of Exeter, Newcastle University, Kings College London, University of Oxford and University of Glasgow)

  Morris, A. (Investigator), Palmer, C. (Investigator) & Pearson, E. (Investigator)

  Medical Research Council

  25/02/13 → 31/05/21

  Project: Research

  • Non Insulin Dependent Diabetes Mellitus 100%
  • Type 2 Diabetes Mellitus (T2DM) 94%
  • Maturity Onset Diabetes of the Young 91%
  • Sodium Glucose Cotransporter 2 Inhibitor 48%
  • Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 47%